Annual EBITDA
-$56.75 M
-$11.96 M-26.70%
31 December 2023
Summary:
Longboard Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$56.75 million, with the most recent change of -$11.96 million (-26.70%) on 31 December 2023. During the last 3 years, it has fallen by -$42.35 million (-294.12%). LBPH annual EBITDA is now -294.13% below its all-time high of -$14.40 million, reached on 31 December 2020.LBPH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$28.12 M
-$2.48 M-9.68%
30 September 2024
Summary:
Longboard Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently -$28.12 million, with the most recent change of -$2.48 million (-9.68%) on 30 September 2024. Over the past year, it has dropped by -$14.54 million (-107.08%). LBPH quarterly EBITDA is now -16062.64% below its all-time high of -$174.00 thousand, reached on 31 March 2020.LBPH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$87.44 M
-$14.54 M-19.95%
30 September 2024
Summary:
Longboard Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$87.44 million, with the most recent change of -$14.54 million (-19.95%) on 30 September 2024. Over the past year, it has dropped by -$34.54 million (-65.28%). LBPH TTM EBITDA is now -50155.75% below its all-time high of -$174.00 thousand, reached on 31 March 2020.LBPH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LBPH EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.7% | -107.1% | -65.3% |
| 3 y3 years | -294.1% | -342.5% | -199.9% |
| 5 y5 years | - | - | - |
LBPH EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -294.1% | at low | -342.5% | at low | -214.1% | at low |
| 5 y | 5 years | -294.1% | at low | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | -294.1% | at low | <-9999.0% | at low | <-9999.0% | at low |
Longboard Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$28.12 M(+9.7%) | -$87.44 M(+19.9%) |
| June 2024 | - | -$25.64 M(+41.6%) | -$72.90 M(+15.9%) |
| Mar 2024 | - | -$18.11 M(+16.3%) | -$62.90 M(+10.8%) |
| Dec 2023 | -$56.75 M(+26.7%) | -$15.57 M(+14.7%) | -$56.75 M(+7.3%) |
| Sept 2023 | - | -$13.58 M(-13.2%) | -$52.91 M(+3.3%) |
| June 2023 | - | -$15.64 M(+30.8%) | -$51.21 M(+8.6%) |
| Mar 2023 | - | -$11.96 M(+2.0%) | -$47.13 M(+5.2%) |
| Dec 2022 | -$44.79 M | -$11.73 M(-1.3%) | -$44.79 M(+7.0%) |
| Sept 2022 | - | -$11.88 M(+2.7%) | -$41.86 M(+15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$11.56 M(+20.2%) | -$36.33 M(+14.4%) |
| Mar 2022 | - | -$9.62 M(+9.4%) | -$31.75 M(+14.1%) |
| Dec 2021 | -$27.84 M(+93.3%) | -$8.79 M(+38.4%) | -$27.84 M(-4.5%) |
| Sept 2021 | - | -$6.36 M(-9.0%) | -$29.15 M(+15.0%) |
| June 2021 | - | -$6.99 M(+22.5%) | -$25.35 M(+27.2%) |
| Mar 2021 | - | -$5.70 M(-43.6%) | -$19.93 M(+38.4%) |
| Dec 2020 | -$14.40 M | -$10.11 M(+296.4%) | -$14.40 M(+235.6%) |
| Sept 2020 | - | -$2.55 M(+62.7%) | -$4.29 M(+146.5%) |
| June 2020 | - | -$1.57 M(+800.6%) | -$1.74 M(+900.6%) |
| Mar 2020 | - | -$174.00 K | -$174.00 K |
FAQ
- What is Longboard Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals annual EBITDA year-on-year change?
- What is Longboard Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Longboard Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Longboard Pharmaceuticals?
- What is Longboard Pharmaceuticals TTM EBITDA year-on-year change?
What is Longboard Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of LBPH is -$56.75 M
What is the all time high annual EBITDA for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$14.40 M
What is Longboard Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, LBPH annual earnings before interest, taxes, depreciation & amortization has changed by -$11.96 M (-26.70%)
What is Longboard Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of LBPH is -$28.12 M
What is the all time high quarterly EBITDA for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$174.00 K
What is Longboard Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, LBPH quarterly earnings before interest, taxes, depreciation & amortization has changed by -$14.54 M (-107.08%)
What is Longboard Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of LBPH is -$87.44 M
What is the all time high TTM EBITDA for Longboard Pharmaceuticals?
Longboard Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$174.00 K
What is Longboard Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, LBPH TTM earnings before interest, taxes, depreciation & amortization has changed by -$34.54 M (-65.28%)